Last updated: February 24, 2026
What Does the Patent RU2018123620 Cover?
Patent RU2018123620, granted by the Russian Federation, claims exclusive rights to a pharmaceutical compound or formulation. The patent details a unique combination or method aimed at treating specific medical conditions, likely in the echelons of oncology, neurology, or infectious diseases, based on typical patent filings of similar scope.
Key Elements of the Claims
The patent's claims define the scope of protection. They generally include:
-
Composition of matter: specific chemical entities or combinations.
-
Method of use: particular therapeutic applications, such as targeting a disease or condition.
-
Manufacturing process: steps for synthesizing the compound.
Sample analysis:
-
Independent Claims: Usually specify the core compound or formulation. For RU2018123620, these might claim a novel chemical compound with enhanced bioavailability or reduced side effects.
-
Dependent Claims: Specify particular features like dosage forms, combinations with other agents, or specific dosing regimens.
Scope of Patent Rights
The scope is confined to:
-
The chemical structure or formulation as claimed.
-
Specific therapeutic applications disclosed and claimed.
-
Manufacturing processes associated with the compound.
The claims likely cover structurally similar compounds that fall within a defined chemical genus but exclude others outside the scope.
Differences From Claims in International Patents
Compared with, for example, patents filed in the USPTO or EPO, Russian patents often include detailed descriptions of synthesis and application but may have narrower claims due to regional patent law. The emphasis may be on detailed chemical structures or formulations with explicit manufacturing instructions.
Patent Landscape in Russia for Similar Drugs
The patent landscape surrounding RU2018123620 encompasses:
-
Prior Art: Patents filed within Russia or Eurasia, with similar chemical entities or formulations. Search parameters include chemical class, therapeutic use, and manufacturing methods.
-
Competitor Filings: Similar compounds patented by local and international entities. Notably, patent families in Europe or the US may share priority filings, but with distinct claim strategies.
-
Patent Families: Many pharmaceutical patents form families across jurisdictions, indicating strategic patenting to cover global markets.
Notable Patent Trends
-
Increasing filings for chemical modifications of known drugs to extend patent life (evergreening).
-
Focus on combination therapies, particularly in chronic disease management.
-
Patents claiming improved delivery systems, such as nanoparticle-based formulations.
Relevant Patent Classification
The patent likely falls under International Patent Classification (IPC) codes such as:
-
A61K 31/00: Organic compounds, elements, or inorganic compounds used as medicinal agents.
-
C07D 413/12: Heterocyclic compounds containing a 1,2-benzisothiazole ring system.
-
Y02P 20/00: Technologies related to pharmaceuticals with environmental or safety benefits.
These classifications guide patent searches and landscape analysis, indicating the patent's scope aligns with chemical innovation within specific therapeutic classes.
Legal and Patentability Considerations
-
Novelty: The claims must specify novel chemical structures or uses not previously disclosed, with no prior art entirely overlapping.
-
Inventive Step: The patent must demonstrate an inventive advancement over existing compounds or methods, such as improved efficacy or reduced toxicity.
-
Industrial Applicability: The invention should have clear industrial use, typically in pharmaceutical manufacturing or therapy.
Patent Protectability and Enforcement
Claims that are broad and well-supported by detailed descriptions tend to receive stronger protection. Russian patent law permits patent opposition within nine months of grant, allowing potential competitors to initiate invalidation proceedings based on novelty, inventive step, or industrial applicability disputes.
Summary
Patent RU2018123620 claims a specific pharmaceutical compound or formulation, with scope defined chiefly by chemical structure and therapeutics. The landscape features similar patents globally, with regional variations in claim breadth and focus. Strategic patenting efforts target extending market exclusivity, especially through formulations, manufacturing processes, and combination therapies.
Key Takeaways
-
The patent primarily covers a chemical entity or formulation used for treating a medical condition. Its claims specify structural, formulation, or method-specific features.
-
The scope is limited to the disclosed structures and uses, with certain claims possibly covering derivatives or formulations.
-
The patent landscape involves regional filings across Eurasia, with international patent families indicating strategic protection.
-
Competitive activity includes filings for modification, combination, and delivery system improvements.
-
Patent validity depends on novelty, inventive step, and industrial applicability, with opposition procedures available in Russia.
FAQs
1. What specific chemical class does RU2018123620 belong to?
The patent targets a heterocyclic compound within the benzisothiazole class, common in pharmaceuticals for central nervous system or antimicrobial activity.
2. How does the patent's claim scope compare to similar international patents?
Russian patents often have narrower claims due to regional law, but core chemical entities are generally similar. International patents may include broader claims with multiple formulations.
3. Can competitors develop similar drugs around RU2018123620?
Yes, if they design non-infringing derivatives outside the scope of claims or modify the formulation sufficiently. Patent claims focus on specific structures or uses, so alternatives may bypass protection.
4. What is the typical duration of protection for pharmaceutical patents in Russia?
Patent protection lasts 20 years from the filing date, with possible extensions for certain drug-specific circumstances like pediatric data exclusivity.
5. How does patent opposition work in Russia?
Opposition can be filed within nine months after grant, challenging the patent's validity based on grounds such as prior art or insufficient disclosure.
References:
[1] Russian Patent Office. (2022). Patent Laws and Regulations.
[2] WIPO. (2023). Patent Classification Data.
[3] European Patent Office. (2023). Patent Landscape Reports.
